116 related articles for article (PubMed ID: 38893707)
1. Advances in Inflammatory Bowel Disease Diagnostics: Machine Learning and Genomic Profiling Reveal Key Biomarkers for Early Detection.
Syed AH; Abujabal HAS; Ahmad S; Malebary SJ; Alromema N
Diagnostics (Basel); 2024 Jun; 14(11):. PubMed ID: 38893707
[TBL] [Abstract][Full Text] [Related]
2. Machine learning-based solution reveals cuproptosis features in inflammatory bowel disease.
Liu L; Liang L; Yang C; Chen Y
Front Immunol; 2023; 14():1136991. PubMed ID: 37275904
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of the Diagnostic Markers for Inflammatory Bowel Disease by Bioinformatics Analysis and Machine Learning.
Tang Q; Shi X; Xu Y; Zhou R; Zhang S; Wang X; Zhu J
Biochem Genet; 2024 Feb; 62(1):371-384. PubMed ID: 37351719
[TBL] [Abstract][Full Text] [Related]
4. The shared circulating diagnostic biomarkers and molecular mechanisms of systemic lupus erythematosus and inflammatory bowel disease.
Sun HW; Zhang X; Shen CC
Front Immunol; 2024; 15():1354348. PubMed ID: 38774864
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
[TBL] [Abstract][Full Text] [Related]
6. Potential shared pathogenic mechanisms between endometriosis and inflammatory bowel disease indicate a strong initial effect of immune factors.
Zhang H; Mo Y; Wang L; Zhang H; Wu S; Sandai D; Shuid AN; Chen X
Front Immunol; 2024; 15():1339647. PubMed ID: 38660311
[TBL] [Abstract][Full Text] [Related]
7. Machine Learning-Based Identification of Colon Cancer Candidate Diagnostics Genes.
Koppad S; Basava A; Nash K; Gkoutos GV; Acharjee A
Biology (Basel); 2022 Feb; 11(3):. PubMed ID: 35336739
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of multiple microarray studies to establish differential diagnostic models of Crohn's disease and ulcerative colitis based on a metalloproteinase-associated module.
Deng J; Zhao N; Lv LP; Ma P; Zhang YY; Xu JB; Zhou XP; Chen ZA; Zhang YY
Front Immunol; 2022; 13():1022850. PubMed ID: 36479126
[TBL] [Abstract][Full Text] [Related]
9. Integrated multiple microarray studies by robust rank aggregation to identify immune-associated biomarkers in Crohn's disease based on three machine learning methods.
Chen ZA; Ma HH; Wang Y; Tian H; Mi JW; Yao DM; Yang CJ
Sci Rep; 2023 Feb; 13(1):2694. PubMed ID: 36792688
[TBL] [Abstract][Full Text] [Related]
10. Identifying possible hub genes and biological mechanisms shared between bladder cancer and inflammatory bowel disease using machine learning and integrated bioinformatics.
Liu J; Wu P; Lai S; Wang J; Wang J; Zhang Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16885-16904. PubMed ID: 37740761
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Analysis of Immune Cell Infiltration and Diagnostic Biomarkers between Ankylosing Spondylitis and Inflammatory Bowel Disease.
Zhang X; Chen T; Qian X; He X
Comput Math Methods Med; 2023; 2023():9065561. PubMed ID: 36643579
[TBL] [Abstract][Full Text] [Related]
12. Identification of Specific Biomarkers and Pathways in the Treatment Response of Infliximab for Inflammatory Bowel Disease: In-Silico Analysis.
Kaddoura R; Ghelani H; Alqutami F; Altaher H; Hachim M; Jan RK
Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983834
[TBL] [Abstract][Full Text] [Related]
13. Machine learning-based integrated identification of predictive combined diagnostic biomarkers for endometriosis.
Zhang H; Zhang H; Yang H; Shuid AN; Sandai D; Chen X
Front Genet; 2023; 14():1290036. PubMed ID: 38098472
[No Abstract] [Full Text] [Related]
14. Exploration of the biomarkers of comorbidity of psoriasis with inflammatory bowel disease and their association with immune infiltration.
Ding RL; Zheng Y; Bu J
Skin Res Technol; 2023 Dec; 29(12):e13536. PubMed ID: 38115636
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods.
Bakir-Gungor B; Hacılar H; Jabeer A; Nalbantoglu OU; Aran O; Yousef M
PeerJ; 2022; 10():e13205. PubMed ID: 35497193
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of Signature Genes and Potential Therapy Targets of Inflammatory Bowel Disease and Periodontitis.
Xiong Z; Fang Y; Lu S; Sun Q; Huang J
J Inflamm Res; 2023; 16():4317-4330. PubMed ID: 37795494
[TBL] [Abstract][Full Text] [Related]
17. Identification of key biomarkers for predicting CAD progression in inflammatory bowel disease via machine-learning and bioinformatics strategies.
Tang X; Zhou Y; Chen Z; Liu C; Wu Z; Zhou Y; Zhang F; Lu X; Tang L
J Cell Mol Med; 2024 Mar; 28(6):e18175. PubMed ID: 38451044
[TBL] [Abstract][Full Text] [Related]
18. Identification CCL2,CXCR2,S100A9 of the immune-related gene markers and immune infiltration characteristics of inflammatory bowel disease and heart failure via bioinformatics analysis and machine learning.
Luo X; Wang R; Zhang X; Wen X; Deng S; Xie W
Front Cardiovasc Med; 2023; 10():1268675. PubMed ID: 38034382
[TBL] [Abstract][Full Text] [Related]
19. Identification of ADAM23 as a Potential Signature for Psoriasis Using Integrative Machine-Learning and Experimental Verification.
Yao P; Jia Y; Kan X; Chen J; Xu J; Xu H; Shao S; Ni B; Tang J
Int J Gen Med; 2023; 16():6051-6064. PubMed ID: 38148887
[TBL] [Abstract][Full Text] [Related]
20. Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approach.
Stemmer E; Zahavi T; Kellerman M; Sinberger LA; Shrem G; Salmon-Divon M
Front Immunol; 2024; 15():1353402. PubMed ID: 38510241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
